NEIMETH INTERNATIONAL is trading at 1.96 as of the 23rd of November 2024. This is a 1.01 percent decrease since the beginning of the trading day. The stock's open price was 1.98. NEIMETH INTERNATIONAL has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for NEIMETH INTERNATIONAL PHARMACEUTICAL are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of May 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Although NEIMETH INTERNATIONAL's alpha and beta are two of the key measurements used to evaluate NEIMETH INTERNATIONAL's performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NEIMETH INTERNATIONAL stock to make a market-neutral strategy. Peer analysis of NEIMETH INTERNATIONAL could also be used in its relative valuation, which is a method of valuing NEIMETH INTERNATIONAL by comparing valuation metrics with similar companies.